| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |